Raquel Hontecillas Selected Research

punicic acid

6/2013	Nutritional protective mechanisms against gut inflammation.
9/2011	Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice.
6/2011	Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice.
1/2011	Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists.
4/2009	Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raquel Hontecillas Research Topics

Disease

31	Inflammation (Inflammations) 01/2022 - 07/2002
18	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 09/2004
18	Colitis 01/2018 - 07/2002
14	Obesity 01/2020 - 12/2006
10	Infections 12/2017 - 01/2010
7	Insulin Resistance 01/2020 - 02/2007
5	Crohn Disease (Crohn's Disease) 01/2022 - 10/2012
4	Ulcerative Colitis 01/2022 - 03/2019
4	Virus Diseases (Viral Diseases) 10/2021 - 10/2003
4	Clostridium Infections 01/2021 - 08/2014
4	Neoplasms (Cancer) 01/2017 - 07/2002
3	Body Weight (Weight, Body) 01/2020 - 06/2010
3	Autoimmune Diseases (Autoimmune Disease) 11/2016 - 07/2002
3	Weight Loss (Weight Reduction) 01/2014 - 04/2010
3	Malnutrition (Nutritional Deficiencies) 01/2014 - 01/2013
3	Weight Gain 01/2012 - 10/2010
2	Type 2 Diabetes Mellitus (MODY) 07/2019 - 03/2011
2	Diarrhea 01/2015 - 01/2014
2	Communicable Diseases (Infectious Diseases) 06/2014 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 12/2011 - 01/2009
2	Atherosclerosis 12/2010 - 07/2002
2	Colorectal Neoplasms (Colorectal Cancer) 09/2010 - 03/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008 - 12/2006
2	Hypertrophy 01/2008 - 02/2007
1	Hemorrhage 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021
1	Hyperplasia 10/2021
1	Invasive Pulmonary Aspergillosis 01/2020
1	Prediabetic State (Prediabetes) 07/2019
1	Papillomavirus Infections 01/2017
1	Reinfection 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2015
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Gastritis 07/2014
1	Immune System Diseases (Immune Disorders) 07/2014
1	Persistent Infection 07/2014
1	Human Influenza (Influenza) 06/2014

Drug/Important Bio-Agent (IBA)

16	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 06/2006
16	PPAR gammaIBA 01/2012 - 07/2002
13	Abscisic AcidIBA 01/2020 - 02/2007
10	Ligases (Synthetase)IBA 01/2020 - 03/2011
10	lanthionineIBA 01/2020 - 03/2011
10	Conjugated Linoleic AcidsIBA 08/2016 - 07/2002
8	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2007
7	Insulin (Novolin)FDA Link 01/2020 - 04/2008
7	Dextrans (Dextran)FDA Link 01/2018 - 06/2006
6	CytokinesIBA 12/2019 - 07/2002
6	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 06/2006
5	punicic acidIBA 06/2013 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 08/2014 - 03/2011
4	Plant Growth Regulators (Plant Hormones)IBA 06/2013 - 04/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
3	Pharmaceutical PreparationsIBA 11/2016 - 06/2014
3	LigandsIBA 06/2014 - 12/2006
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2010 - 01/2010
2	NX-13IBA 01/2022 - 12/2019
2	Antigen-Antibody Complex (Immune Complex)IBA 10/2021 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2012
2	Antiviral Agents (Antivirals)IBA 01/2017 - 10/2003
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 07/2002
2	Pattern Recognition ReceptorsIBA 01/2015 - 12/2014
2	nitazoxanide (NTZ)FDA Link 08/2014 - 06/2013
2	Interleukin-17 (Interleukin 17)IBA 07/2014 - 01/2013
2	Virulence Factors (Pathogenicity Factors)IBA 07/2014 - 06/2013
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 07/2002
2	Dietary Fiber FDA Link 06/2013 - 07/2011
2	eleostearic acidIBA 06/2013 - 01/2011
2	AntigensIBA 01/2013 - 01/2007
2	AzoxymethaneIBA 12/2011 - 03/2010
2	Rosiglitazone (Avandia)FDA Link 01/2011 - 10/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2010 - 06/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007 - 06/2006
2	Messenger RNA (mRNA)IBA 02/2007 - 10/2003
2	Vitamin D FDA LinkGeneric 01/2007 - 07/2002
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	VaccinesIBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 10/2021
1	micaIBA 01/2021
1	Investigational DrugsIBA 01/2020
1	Dextran SulfateIBA 12/2019
1	IonomycinIBA 12/2019
1	Interleukin-8 (Interleukin 8)IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	DiazooxonorleucineIBA 01/2018
1	SodiumIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 12/2017
1	NucleotidesIBA 01/2017
1	AntibodiesIBA 01/2017
1	N,N- bis(benzimidazolylpicolinoyl)piperazineIBA 11/2016
1	AS 8IBA 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2014
1	amixicileIBA 08/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2014
1	interleukin-21 (interleukin 21)IBA 07/2014
1	ChemokinesIBA 07/2014
1	ZincIBA 01/2014

Therapy/Procedure

10	Therapeutics 01/2020 - 08/2010
1	Glycemic Control 01/2020
1	Fecal Microbiota Transplantation 01/2017